Journal Article
L. S. Young, Bermudez, L. E., and Inderlied, C. B.,
“Mycobacteria and AIDS: treatment, prevention and future prospects.”,
Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.
L. S. Young, Gascon, R., Alam, S., and Bermudez, L. E.,
“Monoclonal antibodies for treatment of gram-negative infections.”,
Reviews of infectious diseases, vol. 11 Suppl 7, pp. S1564-71, 1989.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S.,
“Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”,
Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”,
The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
T. Tantawichien, Young, L. S., and Bermudez, L. E.,
“Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages.”,
The Journal of infectious diseases, vol. 174, no. 3, pp. 574-82, 1996.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S.,
“Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.”,
Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.”,
Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Young, L. S., and Enkel, H.,
“Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.”,
Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez, Young, L. S., Martinelli, J., and Petrofsky, M.,
“Exposure to ethanol up-regulates the expression of Mycobacterium avium complex proteins associated with bacterial virulence.”,
The Journal of infectious diseases, vol. 168, no. 4, pp. 961-8, 1993.
L. E. Bermudez, Wu, M., Martinelli, J., and Young, L. S.,
“Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages.”,
Lymphokine and cytokine research, vol. 10, no. 5, pp. 413-9, 1991.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”,
Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S.,
“Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.”,
The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor.”,
Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B.,
“Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.”,
The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez, Shelton, K., and Young, L. S.,
“Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells.”,
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.
C. M. Black, Bermudez, L. E., Young, L. S., and Remington, J. S.,
“Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens.”,
The Journal of experimental medicine, vol. 172, no. 3, pp. 977-80, 1990.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B.,
“Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.”,
Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S.,
“Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.”,
The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S.,
“Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S.,
“An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.”,
The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S.,
“Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.”,
Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.